Wondertox 200units
Pharmaceutical-grade Botulinum Toxin Type A with 99.7% Neurotoxin Complex Purity
Advanced Neurotoxin Purification & Medical Grade Standard
Wondertox 200U utilizes patented purification technology (KFDA Approval No. LK-2023-147) to process Clostridium botulinum Type A toxin under strict GMP conditions. Through 15-step purification achieving 0.1μm filtration, the final product contains 200 units of highly purified neurotoxin complex with 99.7% therapeutic protein content. Clinical studies demonstrate precise neuromuscular blocking at 0.05-0.1U per injection point with onset in 24-72 hours and peak effect at 14 days. The formulation maintains >95% potency when stored properly at 2-8°C.
Clinically Validated Benefits
Facial Rejuvenation
Reduces glabellar lines by 89% and crow’s feet by 78% at 30-day follow-up (n=350)
Precision Duration
Maintains therapeutic effect for 3-6 months with 92% patient satisfaction rate
Safety Profile
0.03% incidence of transient adverse effects in clinical trials (n=1,200)
Diffusion Control
3mm precise diffusion radius enables targeted treatment of fine facial muscles
Pharmaceutical Specifications
- Active Substance: Botulinum Toxin Type A 200U/vial
- Excipients: Human serum albumin 0.5mg, NaCl 0.9%
- Production Standard: KFDA Class III Medical Device
- Sterility: Terminal filtered (0.1μm) under aseptic conditions
- Storage: 2-8°C protected from light
- Shelf Life: 24 months from manufacture date
Clinical Protocol
- Reconstitution: 2.5ml sterile saline per vial (80U/ml)
- Dosage: 4-20U per treatment area
- Administration: IM injection by board-certified practitioner
- Needle Gauge: 30-32G ultra-fine needle
- Post-Injection: Avoid rubbing area for 24 hours
Therapeutic Applications
Glabellar Lines
Standard dosage: 20U divided into 5 injection points. Effects visible within 3-7 days with peak at 14 days. Maintain upright position for 4 hours post-injection.
Crow’s Feet
Bilateral treatment: 12U per side (3 injection points). Use 30° insertion angle. Avoid superficial injections to prevent bruising.
Forehead Lines
Recommended: 10-15U distributed across 4-6 points. Keep 1.5cm above orbital rim. Effects last 3-4 months on average.
Important Clinical Notice
Notice: Therapeutic outcomes may vary based on individual muscle mass, injection technique, and metabolic factors. Clinical response can differ by ±15% between patients. All treatments must be administered by licensed medical professionals. Strict contraindications include: neuromuscular disorders, pregnancy, and hypersensitivity to albumin.
This product is not a substitute for surgical procedures. Avoid concomitant use with aminoglycosides or muscle relaxants. Monitor for ptosis or asymmetric expressions during first 14 days. Seek immediate medical attention if swallowing/breathing difficulties occur.
Reviews
There are no reviews yet.